Adalimumab drug levels at secondary loss of response in Crohn's disease; are we aiming high enough? A retrospective, international multi-centre study

被引：0
|
作者：
Swaine, A. [1 ]
Reynolds, R. [2 ]
Roblin, X. [3 ]
Gibson, D. [1 ]
Martin, C. [4 ]
Irving, P. [2 ]
Sparrow, M. [1 ]
Ward, M. [1 ]
机构：
[1] Alfred Hosp, Gastroenterol, Melbourne, Vic, Australia
[2] Guys & St Thomas Trust, Gastroenterol, London, England
[3] CHU St Etienne, Gastroenterol, St Etienne, France
[4] Monash Univ, Epidemiol & Preventat Med, Melbourne, Vic, Australia
来源：
JOURNAL OF CROHNS & COLITIS | 2020年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P706
引用
收藏
页码：S571 / S572
页数：3
相关论文
共 50 条
  • [1] ADALIMUMAB DRUG LEVELS AT SECONDARY LOSS OF RESPONSE IN CROHN'S DISEASE; ARE WE AIMING HIGH ENOUGH? A RETROSPECTIVE, INTERNATIONAL MULTI-CENTRE STUDY.
    Swaine, Adrian
    Reynolds, Rebecca
    Roblin, Xavier
    Gibson, David J.
    Martin, Catherine A.
    Irving, Peter M.
    Sparrow, Miles
    Ward, Mark G.
    GASTROENTEROLOGY, 2020, 158 (06) : S464 - S464
  • [2] Adalimumab drug levels at secondary loss of response in Crohn's disease: Are we aiming high enough? A retrospective, international multicenter study
    Swaine, A.
    Reynolds, R.
    Roblin, X.
    Irving, P.
    Martin, C.
    Gibson, D.
    Sparrow, M.
    Gibson, P.
    Ward, M.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 117 - 118
  • [3] Adalimumab Drug Levels at Secondary Loss of Response Do Not Predict Response to Dose-intensification in Crohn's Disease: A Retrospective, International Multicenter Study
    Little, Robert D.
    Swaine, Adrian
    Reynolds, Rebecca
    Gibson, David J.
    Barrau, Mathilde
    D'Errico, Francesca
    Hampal, Rumneek
    Sparrow, Miles P.
    Roblin, Xavier
    Irving, Peter M.
    Ward, Mark G.
    INFLAMMATORY BOWEL DISEASES, 2023, 30 (10) : 1714 - 1723
  • [4] Is there a difference in adalimumab drug levels according to pen vs. syringe use: An international, multi-centre retrospective analysis
    Little, R.
    Chu, I.
    van der Zanden, E.
    Flanagan, E.
    Bell, S.
    Sparrow, M.
    Shelton, E.
    Connor, S.
    Roblin, X.
    Ward, M.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S469 - S470
  • [5] 6-Thioguanine nucleotide levels are associated with mucosal healing in patients with Crohn's disease: A multi-centre, international study
    Mao, R.
    Guo, J.
    Luber, R.
    Chen, B. -L.
    He, Y.
    Zeng, Z. -R.
    Ben-Horin, S.
    Sparrow, M.
    Xavier, R.
    Chen, M. -H.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S385 - S385
  • [6] Novel endoluminal parameters to predict primary loss of response in patients with Crohn's disease: a national survey and multi-centre study
    Shen, J.
    Feng, Q.
    Yao, R.
    Cai, C.
    Liang, J.
    Tian, F.
    Cao, X.
    Li, Y.
    Gu, Y.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i845 - i847
  • [7] Adalimumab dose escalation is effective for managing secondary loss of response in Crohn's disease
    Ma, C.
    Huang, V.
    Fedorak, D. K.
    Kroeker, K. I.
    Dieleman, L. A.
    Halloran, B. P.
    Fedorak, R. N.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 40 (09) : 1044 - 1055
  • [8] Therapeutic Drug Monitoring Guides the Management of Crohn's Patients with Secondary Loss of Response to Adalimumab
    Restellini, Sophie
    Chao, Che-yung
    Lakatos, Peter L.
    Aruljothy, Achuthan
    Aziz, Haya
    Kherad, Omar
    Bitton, Alain
    Wild, Gary
    Afif, Waqqas
    Bessissow, Talat
    INFLAMMATORY BOWEL DISEASES, 2018, 24 (07) : 1531 - 1538
  • [9] Adalimumab for patients with Crohn's disease complicated by intra-abdominal abscess: a multi-centre, prospective, observational cohort study
    de Chambrun, G. Pineton
    Pariente, B.
    Seksik, P.
    Altwegg, R.
    Vuitton, L.
    Stefasnescu, C.
    Nancey, S.
    Aubourg, A.
    Serrero, M.
    Peyrin-Biroulet, L.
    Filippi, J.
    Viennot, S.
    Abitbol, V.
    Boualit, M.
    Boureille, A.
    Moreau, J.
    Buisson, A.
    Roblin, X.
    Nachury, M.
    Zappa, M.
    Lambert, J.
    Bouhnik, Y.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S614 - S615
  • [10] Adalimumab for patients with Crohn's disease complicated by intra-abdominal abscess: a multi-centre, prospective, observational cohort study
    de Chambrun, G. Pineton
    Pariente, B.
    Seksik, P.
    Altwegg, R.
    Vuitton, L.
    Stefasnescu, C.
    Nancey, S.
    Aubourg, A.
    Serrero, M.
    Peyrin-Biroulet, L.
    Filippi, J.
    Viennot, S.
    Abitbol, V.
    Boualit, M.
    Boureille, A.
    Moreau, J.
    Buisson, A.
    Roblin, X.
    Nachury, M.
    Zappa, M.
    Lambert, J.
    Bouhnik, Y.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S376 - S377
12345